Epsilon HealthcareHDRPF 12 EV-to-FCF is -6.44 as of Jul. 03, 2026. GuruFocus rates HDRPF with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 562 Drug Manufacturers companies, Epsilon Healthcare ranks worse than 177935.77% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Epsilon Healthcare's Enterprise Value is $13.14 Mil.
Epsilon Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.04 Mil. Therefore, Epsilon Healthcare's EV-to-FCF for today is -6.44.
The historical rank and industry rank for Epsilon Healthcare's EV-to-FCF or its related term are showing as below:
HDRPF'
s EV-to-FCF Range Over the Past 10 Years
Min: -28.45 Med: -4.17 Max: -0.91
Current: -5.97
During the past 9 years, the highest EV-to-FCF of Epsilon Healthcare was -0.91. The lowest was -28.45. And the median was -4.17.
HDRPF's EV-to-FCF is ranked worse than 100% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.525
vs HDRPF: -5.97
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Epsilon Healthcare's PE Ratio (TTM) for today is calculated as:
Epsilon Healthcare's share price for today is $0.0014.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epsilon Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Epsilon Healthcare EV-to-FCF Related Terms
Epsilon Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Epsilon Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epsilon Healthcare EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Epsilon Healthcare's EV-to-FCF falls into.
Epsilon Healthcare's current Enterprise Value is $13.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epsilon Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epsilon Healthcare (HDRPF) has a EV-to-FCF of -6.44 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Epsilon Healthcare and its competitors. According to the industry distribution chart, Epsilon Healthcare ranks #999999 out of 562 companies in the Drug Manufacturers industry.
Is Epsilon Healthcare's EV-to-FCF too high?
Epsilon Healthcare's current EV-to-FCF is -6.44. Based on the distribution chart, Epsilon Healthcare ranks #999999 out of 562 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Epsilon Healthcare has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Epsilon Healthcare's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Epsilon Healthcare ranks #999999 out of 562 companies for EV-to-FCF. This places Epsilon Healthcare in the lower half of its industry. The industry median EV-to-FCF is 20.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.53, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Epsilon Healthcare and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epsilon Healthcare's current EV-to-FCF is -6.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Epsilon Healthcare (HDRPF) has a current EV-to-FCF of -6.44. The current EV-to-FCF is -6.44. Epsilon Healthcare's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Epsilon Healthcare (HDRPF), the current EV-to-FCF is -6.44 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.
12GF Score
Get the complete analysis for HDRPF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HDRPF has been successfully added to your 
